Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG

  • Authors:
    • Fengyi Wang
    • Yuancui Li
    • Fengzhi Shan
    • Qinglei Zhang
    • Lei Wang
    • Bin Sheng
    • Guangzhou Cheng
  • View Affiliations

  • Published online on: July 23, 2019     https://doi.org/10.3892/or.2019.7246
  • Pages: 1431-1440
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Jumonji domain‑containing protein 2A (JMJD2A) has been identified to promote cell proliferation in bladder cancer; however, it remains undetermined whether JMJD2A regulates cell migration and invasion in bladder cancer. The aim of the present study was to further investigate the roles of JMJD2A in bladder cancer. The expression levels of JMJD2A in bladder cancer tissues and cell lines were established by RT‑qPCR assays and western blot analysis. Moreover, by gain‑ and loss‑of‑function assays, the effects of JMJD2A on migration and invasion as well as proliferation were investigated in bladder cancer cells. The results revealed that the expression level of JMJD2A was significantly upregulated in bladder cancer tissues and cell lines compared to adjacent non‑tumor tissues and a human immortalized bladder urothelial cell line. Kaplan‑Meier survival analysis indicated that patients with high JMJD2A expression level had shorter overall survival. Moreover, JMJD2A could promote cell migration and invasion by facilitating epithelial‑mesenchymal transition (EMT) in bladder cancer. In addition, it was determined that JMJD2A promoted EMT through regulation of SLUG expression. Collectively, our findings revealed that JMJD2A may act as an oncogene and participate in bladder cancer progression, which provides a promising therapeutic strategy for patients with bladder cancer.

References

1 

Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Jin Y, Lu J, Wen J, Shen Y and Wen X: Regulation of growth of human bladder cancer by miR-192. Tumour Biol. 36:3791–3797. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Berry WL and Janknecht R: KDM4/JMJD2 histone demethylases: Epigenetic regulators in cancer cells. Cancer Res. 73:2936–2942. 2013. View Article : Google Scholar : PubMed/NCBI

5 

Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E and Dangond F: Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem. 280:28507–28518. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Zhang D, Yoon HG and Wong J: JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2). Mol Cell Biol. 25:6404–6414. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Li BX, Zhang MC, Luo CL, Yang P, Li H, Xu HM, Xu HF, Shen YW, Xue AM and Zhao ZQ: Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro. J Exp Clin Cancer Res. 30:902011. View Article : Google Scholar : PubMed/NCBI

8 

Berry WL, Shin S, Lightfoot SA and Janknecht R: Oncogenic features of the JMJD2A histone demethylase in breast cancer. Int J Oncol. 41:1701–1706. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, Scherr DS, Gudas LJ and Mongan NP: Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog. 50:931–944. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Kogure M, Takawa M, Cho HS, Toyokawa G, Hayashi K, Tsunoda T, Kobayashi T, Daigo Y, Sugiyama M, Atomi Y, et al: Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition. Cancer Lett. 336:76–84. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Mallette FA and Richard S: JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. Cell Rep. 2:1233–1243. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Kim TD, Shin S, Berry WL, Oh S and Janknecht R: The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. J Cell Biochem. 113:1368–1376. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Bryan RT: Cell adhesion and urothelial bladder cancer: The role of cadherin switching and related phenomena. Philos Trans R Soc Lond B Biol Sci. 370:201400422015. View Article : Google Scholar : PubMed/NCBI

14 

Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Muramaki M, Miyake H, Terakawa T, Kumano M, Sakai I and Fujisawa M: Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection. Urol Oncol. 30:161–166. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Han B, Cui D, Jing Y, Hong Y and Xia S: Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch. World J Urol. 32:149–155. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

18 

Zhi Y, Pan J, Shen W, He P, Zheng J, Zhou X, Lu G, Chen Z and Zhou Z: Ginkgolide B inhibits human bladder cancer cell migration and invasion through microRNA-223-3p. Cell Physiol Biochem. 39:1787–1794. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Wan J, Zhan J, Li S, Ma J, Xu W, Liu C, Xue X, Xie Y, Fang W, Chin YE and Zhang H: PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression. Nucleic Acids Res. 43:3591–3604. 2015. View Article : Google Scholar : PubMed/NCBI

20 

McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Gonzalez DM and Medici D: Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 7:re82014. View Article : Google Scholar : PubMed/NCBI

22 

Yun SJ and Kim WJ: Role of the epithelial-mesenchymal transition in bladder cancer: From prognosis to therapeutic target. Korean J Urol. 54:645–650. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 42 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, F., Li, Y., Shan, F., Zhang, Q., Wang, L., Sheng, B., & Cheng, G. (2019). Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG. Oncology Reports, 42, 1431-1440. https://doi.org/10.3892/or.2019.7246
MLA
Wang, F., Li, Y., Shan, F., Zhang, Q., Wang, L., Sheng, B., Cheng, G."Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG". Oncology Reports 42.4 (2019): 1431-1440.
Chicago
Wang, F., Li, Y., Shan, F., Zhang, Q., Wang, L., Sheng, B., Cheng, G."Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG". Oncology Reports 42, no. 4 (2019): 1431-1440. https://doi.org/10.3892/or.2019.7246